A causal link between chronic spontaneous urticaria and gut microbiota, with metabolic pathways potentially acting as ...

Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...

About LYR-210 LYR-210 is an investigational product candidate for the treatment of chronic rhinosinusitis (CRS) in patients who have failed current therapies and require further intervention.

The association between chronic rhinosinusitis and obesity was explored after adjusting ... Further investigations on the mechanism of this correlation is anticipated for elucidating the pathogenesis ...

Beyond CSU, Dupixent is approved in the US for certain cases of atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic oesophagitis, prurigo nodularis and chronic ...

The epigenetic landscape of chronic rhinosinusitis (CRS) has advanced, but the causal microRNAs (miRNAs) in its pathogenesis remain undefined. Researchers conducted a retrospective study to identify ...

New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in addition to asthma Itepekimab expanding into chronic ...

A sinus infection is inflammation of the sinuses, which are the air spaces around your nose, eyes, cheeks, and forehead. It is also called sinusitis. When the sinuses are inflamed, drainage is blocked ...

Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a history of chronic rhinosinusitis with nasal polyps, but its efficacy and ...

Trump’s pick to lead the Department of Health and Human Services, has for years called attention to what he considers an “epidemic” of chronic disease that has left America’s children ...

The pounding that sailors’ brains take from years of high-speed wave-slamming in the Special Boat Teams can cause symptoms that wreck their careers — and their lives. Members of the Navy’s ...